Yu F - Search Results

1

A phase II trial of epirubicin, oxaliplatin, and capecitabine (EOX) as first-line chemotherapy in advanced gastric cancer: a Chinese single-center experience.

Xiang XJ, Qiu F, Xiong JP, Zhang L, Yu F, Feng M, Zhan ZY. Xiang XJ, et al. Among authors: yu f. Chemotherapy. 2010;56(3):171-7. doi: 10.1159/000313975. Epub 2010 Apr 28. Chemotherapy. 2010. PMID: 20424444 Clinical Trial.

2

A phase II trial of modified FOLFOX as first-line chemotherapy in advanced colorectal cancer.

Xiong JP, Zhang L, Zhong LX, Qiu F, Xu J, Tao QS, Xiang XJ, Yu F, Tang XM. Xiong JP, et al. Among authors: yu f. Anticancer Drugs. 2007 Oct;18(9):1103-7. doi: 10.1097/CAD.0b013e3281722010. Anticancer Drugs. 2007. PMID: 17704661 Clinical Trial.

3

Phase II trial of low-dose gemcitabine in prolonged infusion and cisplatin for advanced non-small cell lung cancer.

Xiong JP, Feng M, Qiu F, Xu J, Tao QS, Zhang L, Xiang XJ, Zhong LX, Yu F, Ma XT, Gong WY. Xiong JP, et al. Among authors: yu f. Lung Cancer. 2008 May;60(2):208-14. doi: 10.1016/j.lungcan.2007.10.004. Epub 2007 Nov 19. Lung Cancer. 2008. PMID: 18023915 Clinical Trial.

4

A phase II study of modified FOLFOX as first-line chemotherapy in elderly patients with advanced gastric cancer.

Zhao JG, Qiu F, Xiong JP, Zhang L, Xiang XJ, Yu F, Yan J, Zhan ZY, Feng M. Zhao JG, et al. Among authors: yu f. Anticancer Drugs. 2009 Apr;20(4):281-6. doi: 10.1097/CAD.0b013e328324bbc1. Anticancer Drugs. 2009. PMID: 19247179 Clinical Trial.

5

A phase II trial of epirubicin plus oxaliplatin and fluorouracil as first-line chemotherapy for advanced gastric cancer.

Zhao JG, Xiong JP, Xiang XJ, Qiu F, Zhang L, Yu F. Zhao JG, et al. Among authors: yu f. Ai Zheng. 2009 Jan;28(1):42-4. Epub 2009 Jan 5. Ai Zheng. 2009. PMID: 19448415 Free article. Clinical Trial.

6

A phase II study of capecitabine plus oxaliplatin as first-line chemotherapy in elderly patients with advanced gastric cancer.

Xiang XJ, Zhang L, Qiu F, Yu F, Zhan ZY, Feng M, Yan J, Zhao JG, Xiong JP. Xiang XJ, et al. Among authors: yu f. Chemotherapy. 2012;58(1):1-7. doi: 10.1159/000335585. Epub 2012 Feb 3. Chemotherapy. 2012. PMID: 22310723 Clinical Trial.

7

A phase II study of modified FOLFOX as first-line chemotherapy in advanced small bowel adenocarcinoma.

Xiang XJ, Liu YW, Zhang L, Qiu F, Yu F, Zhan ZY, Feng M, Yan J, Zhao JG, Xiong JP. Xiang XJ, et al. Among authors: yu f. Anticancer Drugs. 2012 Jun;23(5):561-6. doi: 10.1097/CAD.0b013e328350dd0d. Anticancer Drugs. 2012. PMID: 22481063 Clinical Trial.

8

A study of weekly docetaxel and carboplatin as first-line chemotherapy for advanced non-small cell lung cancer.

Jiang H, Zhang X, Chen J, Zhang L, Xiong J, Zhong L, Yu F, Qian J, Yu L, Wang X, Shi G, Deng J, Xu N. Jiang H, et al. Among authors: yu l, yu f. J Thorac Dis. 2014 Feb;6(2):79-85. doi: 10.3978/j.issn.2072-1439.2014.01.24. J Thorac Dis. 2014. PMID: 24605220 Free PMC article.

9

miR-320 enhances the sensitivity of human colon cancer cells to chemoradiotherapy in vitro by targeting FOXM1.

Wan LY, Deng J, Xiang XJ, Zhang L, Yu F, Chen J, Sun Z, Feng M, Xiong JP. Wan LY, et al. Among authors: yu f. Biochem Biophys Res Commun. 2015 Feb 6;457(2):125-32. doi: 10.1016/j.bbrc.2014.11.039. Epub 2014 Nov 21. Biochem Biophys Res Commun. 2015. PMID: 25446103

10

[Establishment and biological characterization of 5-fluorouracil-resistant human colon cancer HT-29/5-FU cell line].

Qiu T, Xiang X, Lei W, Hao C, Zhang L, Feng M, Yu F, Li J, Xiong J. Qiu T, et al. Among authors: yu f. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2015 Mar;31(3):328-32. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2015. PMID: 25744837 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,954 results

Search Page

Filters